Skip to content
KDMKDMKDM200200200

Drawing based on the description in the official product monograph. No photo yet.

“REZUROCK is available as 200 mg pale yellow, oblong tablets, debossed with "KDM" on one side and "200" on the other side”

KDM 200 pill

Pill with imprint KDM 200 is yellow, capsule and has been identified as Belumosudil Mesylate 200 mg. It is supplied by Sanofi-Aventis Canada Inc.

Sold in Canada

Belumosudil Mesylate 200 mg

Brand
Rezurock
Imprint
KDM 200
Strength
200 mg
Color
Yellow
Shape
Capsule / oblong
Form
Tablet
Manufacturer
Sanofi-Aventis Canada Inc
Sold in
Canada
DIN
02526115

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Belumosudil pills and guides

What is Belumosudil used for?

Official uses from the US prescribing label

REZUROCK is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.

From the FDA-approved label on DailyMed (published Apr 09, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows KDM 200. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, capsule.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Rezurock by Sanofi-Aventis Canada Inc.

In Canada: prescription only.

Ingredients

Active: Belumosudil (Belumosudil Mesylate)

Other pills with imprint KDM 200

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.